NDC 62542-030 – Amphetamine Extended-Release
Amphetamine 18.8 mg/1 · Tablet, Orally Disintegrating · Oral
Product NDC62542-030
Product details
- Brand name
- Amphetamine Extended-Release
- Generic name
- Amphetamine Extended-Release
- Labeler
- Neos Therapeutics, LP
- Dosage form
- Tablet, Orally Disintegrating
- Route
- Oral
- Marketing category
- NDA AUTHORIZED GENERIC · NDA204326
- Marketed since
- September 1, 2025
- Listing expires
- December 31, 2026
- Pharmacologic class
- Central Nervous System Stimulant
Active ingredients
- Amphetamine 18.8 mg/1
Uses, dosage, side effects and warnings for Amphetamine Extended-Release →
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 62542-030-30 | 30 BLISTER PACK in 1 CARTON (62542-030-30) / 6 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK | Sep 1, 2025 |
Other Amphetamine Extended-Release products
- 62542-005 Amphetamine 3.1 mg/1 · Tablet, Orally Disintegrating · Neos Therapeutics, LP
- 62542-010 Amphetamine 6.3 mg/1 · Tablet, Orally Disintegrating · Neos Therapeutics, LP
- 62542-015 Amphetamine 9.4 mg/1 · Tablet, Orally Disintegrating · Neos Therapeutics, LP
- 62542-020 Amphetamine 12.5 mg/1 · Tablet, Orally Disintegrating · Neos Therapeutics, LP
- 62542-025 Amphetamine 15.7 mg/1 · Tablet, Orally Disintegrating · Neos Therapeutics, LP